Source: Myeloma : nature.com subject feeds
Post Content
IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma
by | May 26, 2023 | Myeloma News | 0 comments
Recent Content
- The [(18)F]FDG PET/CT for prognostic stratification in multiple myeloma: A systematic review and meta-analysis
- (no title)
- Teclistamab-daratumumab snag FDA approval in multiple myeloma
- Experimental therapy outperforms approved treatment in PNET trial
- (no title)
- New targeted therapy for childhood brain cancer nears European approval
- New trial data show alnodesertib may slow ovarian cancer progression
- (no title)
- IMF launches Myeloma Action Month to raise global awareness this March
- Cluster of differentiation 38 monoclonal antibody therapy in the treatment of multiple myeloma: a systematic review and meta-analysis